Collis Steven H
Bausch + Lomb Corporation · Director
Collis Steven H is listed in filings as Director at Bausch + Lomb Corporation. This profile follows SEC Form 4 activity through May 28, 2026, including purchase activity and sale activity. Recent filings connect the profile to Bausch + Lomb Corporation (BLCO), Elevance Health Inc (ELV), and Cencora Inc (COR). The current snapshot covers public activity from Nov 13, 2024 to May 28, 2026. Reported amounts are shown as $250.0K to $869.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $267k15k shares | BuyFeb 23, 2026 | $17.81 | $16.36 | |
| $9M31.4k shares | SellSep 16, 2025 | $289.86 | $303.07 | |
| $4M14.6k shares | SellAug 19, 2025 | $289.98 | $303.07 | |
| $4M14.6k shares | SellJul 22, 2025 | $292.67 | $303.07 | |
| $4M14.6k shares | SellJun 24, 2025 | $292.62 | $303.07 | |
| $4M14.6k shares | SellMay 20, 2025 | $293.84 | $303.07 | |
| $4M14.6k shares | SellApr 22, 2025 | $281.81 | $303.07 | |
| $3M12.6k shares | SellMar 25, 2025 | $269.51 | $303.07 | |
| $539k2k shares | SellMar 25, 2025 | $269.51 | $303.07 | |
| $3M12.6k shares | SellFeb 27, 2025 | $251.08 | $303.07 | |
| $12M50k shares | SellNov 25, 2024 | $243.98 | $303.07 | |
| $5M21.5k shares | SellNov 19, 2024 | $242.16 | $303.07 |